Jinling Pharmaceutical Co Ltd banner
J

Jinling Pharmaceutical Co Ltd
SZSE:000919

Watchlist Manager
Jinling Pharmaceutical Co Ltd
SZSE:000919
Watchlist
Price: 7.3 CNY 0.27% Market Closed
Market Cap: ¥4.5B

Jinling Pharmaceutical Co Ltd's latest stock split occurred on Jul 10, 2006

The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.

The adjusted shares began trading on Jul 10, 2006. This was Jinling Pharmaceutical Co Ltd's 3rd stock split, following the previous one in Feb 7, 2006.

Last Splits:
Jul 10, 2006
1-for-1
Feb 7, 2006
13-for-10
Aug 17, 2004
12-for-10
Pre-Split Price
N/A
Post-Split Price
7.923
Before
After
Last Splits:
Jul 10, 2006
1-for-1
Feb 7, 2006
13-for-10
Aug 17, 2004
12-for-10

Jinling Pharmaceutical Co Ltd
Stock Splits History

Jinling Pharmaceutical Co Ltd Stock Splits Timeline
Jul 10, 2006
Jul 10, 2006
Split 1-for-1
/1
Pre-Split Price
N/A
Post-Split Price
7.923
Before
After
Feb 7, 2006
Feb 7, 2006
Split 13-for-10
x1.3
Pre-Split Price
N/A
Post-Split Price
7.923
Before
After
Aug 17, 2004
Aug 17, 2004
Split 12-for-10
x1.2
Pre-Split Price
N/A
Post-Split Price
7.923
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 29, 2026
Anhui Anfu Battery Technology Co Ltd
SSE:603031
29-for-20
x1.45
57.42 39.48 CNY 41.08 41.08 CNY
Apr 29, 2026
S
Shaanxi Meineng Clean Energy Corp Ltd
SZSE:001299
1-for-1
x1
15.61 11.5077 CNY 11.39 11.39 CNY
Apr 29, 2026
L
Leenos Corp
KOSDAQ:039980
1-for-5
/5
1481 7405 KRW 9630 9630 KRW
Apr 29, 2026
A
Alticast Corp
KOSDAQ:085810
1-for-5
/5
437 2185 KRW 2465 2465 KRW
Apr 29, 2026
P
Polaris Uno Inc
KOSDAQ:114630
1-for-5
/5
473 2365 KRW 2465 2465 KRW
Load More

Jinling Pharmaceutical Co Ltd
Glance View

Market Cap
4.5B CNY
Industry
Pharmaceuticals

Jinling Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 4,865 full-time employees. The Company’s main products include Mailuoning injections, ferrous succinate tablets and Lentinan injection, among others. The firm is also involved in the provision of medical services and the sale of medical instrument. The firm distributes its products in domestic market, with North China as its main market.

Intrinsic Value
5.16 CNY
Overvaluation 29%
Intrinsic Value
Price ¥7.3
J
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett